Jesus Berdeja

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Jesus Berdeja

Mar 18, 2025, 09:09 | Science

Myeloma Paper of the Day, March 18th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson…

Jan 30, 2025, 11:29 | Blog

Navneet Majhail: Access barriers to anti-CD19+ CART therapies for lymphoma

Navneet Majhail, Physician-in-Chief of Blood Cancers at Sarah Cannon, shared on LinkedIn: "Hot off the…

Jan 29, 2025, 10:06 | Blog

Rahul Banerjee: Sequencing immunotherapy for treatment of multiple myeloma

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, shared on X: "Honor being part of…

Jun 11, 2024, 12:59 | Insight

Myeloma Paper of the Day, June 11th, suggested by Robert Orlowski

Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase II trial of ixazomib/daratumumab/dexamethasone…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023